538-32-9 | Benzylurea

Packsize	Purity	Availability	Price	Discounted Price
1g	96%	in stock	$10.00	$7.00
5g	96%	in stock	$14.00	$10.00
25g	96%	in stock	$23.00	$17.00
100g	95%	in stock	$58.00	$41.00

Description

• Catalog Number: AB71071
• Chemical Name: Benzylurea
• CAS Number: 538-32-9
• Molecular Formula: C8H10N2O
• Molecular Weight: 150.1778
• MDL Number: MFCD00007951
• SMILES: NC(=O)NCc1ccccc1
• NSC Number: 109103

Computed Properties

• Complexity: 130
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 2
• XLogP3: 0.7

Literature

• Synthesis of unsymmetrical diarylureas via Pd-catalyzed C-N cross-coupling reactions.

  Organic letters 20110617

• Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity.

  Journal of enzyme inhibition and medicinal chemistry 20110601

• A review on phytochemical and pharmacological investigations of miswak (Salvadora persica Linn).

  Journal of pharmacy & bioallied sciences 20110101

• Phenyl- and benzylurea cytokinins as competitive inhibitors of cytokinin oxidase/dehydrogenase: a structural study.

  Biochimie 20100801

• Salvadora persica.

  Pharmacognosy reviews 20100101

• Synthesis of a TRPV1 receptor antagonist.

  The Journal of organic chemistry 20091218

• New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists.

  Journal of medicinal chemistry 20081225

• S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

  Psychopharmacology 20080901

• Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity.

  Bioorganic & medicinal chemistry letters 20080715

• Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.

  Bioorganic & medicinal chemistry 20080601

• Small molecule inhibitors of integrin alpha2beta1.

  Journal of medicinal chemistry 20071101

• Benzylamides from Salvadora persica.

  Archives of pharmacal research 20061101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Versatile access to benzhydryl-phenylureas through an unexpected rearrangement during microwave-enhanced synthesis of hydantoins.

  Organic letters 20031002